Program Description
Evidence suggests that the uptake of preexposure prophylaxis (PrEP) use in the United States remains low despite substantial HIV risk, and studies indicate that over 50% of people who use PrEP discontinue preventive treatments within 6-12 months. PrEP persistence, or sustaining PrEP use over time, has become a critical challenge in PrEP implementation. There are many challenges to optimizing the use of PrEP among at-risk individuals, and pharmacists in community settings can help overcome these barriers. This activity will provide a review of the current state of HIV PrEP in the United States and current options for PrEP, with a review of the newest long-acting agent and other emerging therapies. Pharmacist strategies to improve access and persistence with PrEP will also be presented.
Target audience: Retail pharmacists
Type of activity: Knowledge
Release date: July 29, 2022
Expiration date: July 29, 2023
Time to complete activity: 0.75 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Discuss currently available options for preexposure prophylaxis (PrEP) in the prevention of HIV
- Describe the role of pharmacists in improving PrEP uptake in the United States
Drew W. Cates, PharmD, AAHIVP
Educational Manager
SynerGrx
Chamblee, Georgia
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Drew W. Cates, PharmD, AAHIVP, has the following financial relationship with a commercial interest to disclose:
Speakers Bureau: Gilead
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Buszka, PharmD, BCPS, CHCP; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms